Andrew Reibman is admitted to practice in the New Jersey, New York, and by the United States Patent and Trademark Office. He is not currently admitted in North Carolina.
Andrew Reibman represents clients in intellectual property matters, including patent and trademark preparation and prosecution, IP licensing and corporate transactions, and IP litigation. Andrew has a strong technical and business background, and long experience in both patent and trademark prosecution and contentious matters. He advises clients on IP strategy, setting up or improving IP creation programs, licensing, IP clearance for new products, IP issues and diligence related to corporate transactions, and planning IP enforcement programs. He also has handled many sales and purchases of IP assets, including a number of bankruptcy-related transactions.
Andrew has extensive business experience in software and telecommunication networks, and worked eight years at AT&T Bell Laboratories. Andrew frequently represents clients, from high tech startups to large enterprises, who have legal issues related to computer software, hardware, and networks. Relevant computer technologies he has worked with include operating systems, cloud computing, virtualization, databases and data warehousing, fault-tolerant computing, network architecture and routing, wireless LANs, network testing, system and network administration, RAM and flash memory, fault detection, security and encryption, cable television, optoelectronics and optical communication, semiconductors, computer architecture, disk drives and storage architecture, image and signal processing, machine learning and pattern recognition, RFID, fintech, and digital advertising and marketing, and online betting and gaming.
Andrew also regularly represents clients in other technology areas, for example:
- medical devices -- including cardiac stents, digital mammography, cardiac imaging, blood filters, infusion pumps, robotic surgical systems, cold chain management, historical temperature indicators for vaccines and biologics, and safety syringes;
- construction and building materials -- including bridges, fiberglass doors and windows, modular construction technology, concrete technology, and drywall patches;
- pharmaceuticals, plastics manufacturing, food, beverage and agriculture, consumer products, aircraft technology and maintenance, automotive technology, and railroad equipment.